Kaori Taniguchi
Tokyo, 1130033, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Two independent modes of kidney stone suppression achieved by AIM/CD5L and KIM-1.
Journal: Communications biology
Published: March 02, 2022
Amyloid-β oligomers interact with NMDA receptors containing GluN2B subunits and metabotropic glutamate receptor 1 in primary cortical neurons: Relevance to the synapse pathology of Alzheimer's disease.
Journal: Neuroscience research
Published: October 14, 2021
AIM/CD5L attenuates DAMPs in the injured brain and thereby ameliorates ischemic stroke.
Journal: Cell reports
Published: January 22, 2021
Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
Journal: Journal of Alzheimer's disease : JAD
Published: June 23, 2019
TFEB-mediated Enhancement of the Autophagy-lysosomal Pathway Dually Modulates the Process of Amyloid β-Protein Generation in Neurons.
Journal: Neuroscience
Published: August 18, 2018
Two new coumarins and a new xanthone from the leaves of Rhizophora mucronata.
Journal: Bioorganic & medicinal chemistry letters
Published: December 13, 2017
Inflammatory and anti-inflammatory states of adipose tissue in transgenic mice bearing a single TCR.
Inflammatory and anti-inflammatory states of adipose tissue in transgenic mice bearing a single TCR.
Journal: International immunology
Published: December 23, 2016
The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model.
Journal: Molecular brain
Published: October 14, 2016
Circulating AIM prevents hepatocellular carcinoma through complement activation.
Journal: Cell reports
Published: February 22, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026